Research from EvaluatePharma predicts the orphan drug market will grow 11% each year to 2024.
The Beating Cancer Is in Our Blood brand positioning was developed with Oberland.
At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation
For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.
Botox Cosmetic has rolled out its first ad campaign focused on reaching male customers.
Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.
Opdivo's commercial potential will likely take a hit in the wake of new Keytruda data, but the impact may depend on the ability of BMS to market the message that its I-O/I-O combo allows patients to delay chemo.
The National Association of Cannabis Businesses has released the first national advertising rules for the cannabis industry.
As with most drug pricing battles, patients yet again are caught in the crossfire.
GCI Health, HealthyWomen, and Redbook magazine are using survey insights to inform the HealthiHer movement.